The chemical stability of L-isoleucine,L-threonine,and L-serine in aqueous solutions of KCl at 298.15 K

The experimental saturated solubilities of L-isoleucine, L-threonine, and L-serine in aqueous mixtures of a KCl solution at 298.15 K are presented in this article. The solubilities are measured by gravimetric method. In the present study the theoretical calculation of the standard transfer Gibbs free energy, cavity forming enthalpy of transfer, cavity forming transfer Gibbs free energy, dipole-dipole interaction effect have been computed. The chemical effects of the transfer Gibbs energies for the present amino acids have been obtained by subtracting the cavity effects and dipole-dipole interaction effects from the ΔG_t⁰(i). The stability of the experimental amino acids in aqueous KCl in terms of thermodynamic parameters is explained.     

13X分子筛负载Fe催化剂上1,4-二氧六环在空气中完全氧化(英文)

采用浸渍法制备了不同Fe含量的13X分子筛负载的Fe催化剂(Fe/X13),运用N_2吸附-脱附法测得其BET比表面积和BJH孔径分布,采用X射线衍射、扫描电镜、程序升温还原和NH_3程序升温脱附法表征了该催化剂的织构性质.在固定床流动反应器中,以空气为氧化剂、在100-400℃范围内考察了Fe/X13催化剂上1,4-二氧六环的完全氧化反应性能,研究了反应温度、金属担载量和气体空速(GHSV)等条件对催化氧化降解二氧六环反应性能的影响,并在400℃测定了该催化剂反应50h的稳定性,结果表明,6 wt%Fe/13X催化剂表现出最高的催化性能,在400℃,GHSV=24000 h~(-1)的条件下,二氧六环转化率为97%,生成CO和CO_2的选择性达95%,降解产物还包括少量的乙醛、乙二醇-甲酸酯、乙二醇二甲酸、1,4-二氧六环-2醇、1,4-二氧六环-2酮及2-甲氧基1,3二氧戊环.基于这些经色谱-质谱联用仪检测出的产物,提出了可能的1,4-二氧六环降解机理。     

Synthesis of Novel Drug‐Like Small Molecules Based on Quinoxaline Containing Amino Substitution at C‐2

A series of novel “drug‐like” small molecules based on quinoxaline containing amino substitution at C‐2 were synthesized. All these molecules were prepared either via the reaction of 2‐phenyl‐3‐(piperazin‐1‐yl)quinoxaline with acyl bromides or benzyl bromides or various carboxylic acids or via the reaction of 2‐chloro‐3‐phenylquinoxaline with various amines. The structures of these novel compounds were confirmed by spectral analysis. The strategy used is simple and efficient and afforded good yields of quinoxaline derivatives.     

Full Solution‐Processed Synthesis and Mechanisms of a Recyclable and Bifunctional Au/ZnO Plasmonic Platform for Enhanced UV/Vis Photocatalysis and Optical Properties

The synthesis of noble metal/semiconductor hybrid nanostructures for enhanced catalytic or superior optical properties has attracted a lot of attention in recent years. In this study, a facile and all‐solution‐processed synthetic route was employed to demonstrate an Au/ZnO platform with plasmonic‐enhanced UV/Vis catalytic properties while retaining strengthened luminescent properties. The visible‐light response of photocatalysis is supported by localized surface plasmon resonance (LSPR) excitations while the enhanced performance under UV is aided by charge separation and strong absorption. The enhancement in optical properties is mainly due to local field enhancement effect and coupling between exciton and LSPR. Luminescent characteristics are investigated and discussed in detail. Recyclability tests showed that the Au/ZnO substrate is reusable by cleaning and has a long shelf life. Our result suggests that plasmonic enhancement of photocatalytic performance is not necessarily a trade‐off for enhanced near‐band‐edge emission in Au/ZnO. This approach may give rise to a new class of versatile platforms for use in novel multifunctional and integrated devices.     

Development and validation of LC–QTOF–MS/MS method for the identification and determination of low levels of a genotoxic impurity, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine in ticagrelor API

The foremost objective of the present study was to develop and validate a new LC–QTOF–MS/MS method for the identification and quantitative determination of 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine (DPP) genotoxic impurity through the derivatization process in ticagrelor active pharmaceutical ingredient (API). Owing to the low response of DPP at the specification level, DPP was converted to 4,6-dibenzylamino-5-nitro-2-(propylthio)pyrimidine (DPP derivative) by addition of benzyl amine, then analyzed using mass spectrometry with a time-of-flight analyzer, and good separation was accomplished under the experimental conditions described. The effective separation of DPP derivative was achieved using an Acquity UPLC BEH C₁₈ reverse-phase column (100 × 4.6 mm × 1.7 μm) with an isocratic program with mobile phase A as 0.1% formic acid in milli Q water and mobile phase B as acetonitrile in the ratio of 20:80 v/v. The flow rate was maintained as 0.4 ml/min, the injection volume was 2 μl, the autosampler temperature was 5°C, the column oven temperature was ambient and the run time was 6.0 min. The diluent used was 0.2% benzyl amine in water and acetonitrile in the ratio of 30:70 v/v. The retention time of the DPP derivative was 2.87 min. The limit of detection and limit of quantification were 0.03 and 0.08 ppm, respectively. The DPP derivative was linear from 1.68 to 12.78 ppm with R² of 0.9958. Thus, the developed method is valid for the identification and quantitative determination of DPP derivative in ticagrelor API.     

Stability-indicating HPLC method development and validation for simultaneous estimation of metformin,dapagliflozin, and saxagliptin in bulk drug and pharmaceutical dosage form

A simple, precise, and rapid stability-indicating reversed-phase-HPLC method was developed and validated for the estimation of metformin (MET), dapagliflozin (DAP), and saxagliptin (SAX) combination in bulk and tablet dosage forms. The proposed method uses a Kromasil C18 column (150 × 4.6 mm, 5 μm) with column oven temperature of 30°C and mobile phase containing a mixture of 60% phosphate buffer (pH = 3) and 40% acetonitrile. The flow rate was set at 1.0 mL/min, and the injection volume was 10 μL. The detection was carried out at 230 nm using a photodiode array detector, and the total run time was 4 min. The proposed method was validated according to International Council for Harmonisation (ICH) guidelines for specificity, linearity, precision, accuracy, robustness, and solution stability. The method is linear over the range of 125–750 μg/mL for MET, 1.25–7.5 μg/mL for DAP, and 0.625–3.75 μg/mL for SAX. The observed correlation coefficients (R²) for MET, DAP, and SAX are >0.999. The proposed method is precise, and the percentage relative standard deviation was found to be between 0.4 and 0.8. The observed percentage recoveries were between 98.51 and 100.80 for all three compounds. The product was subjected to stress conditions of acid, base, oxidative, thermal, and photolytic degradation. The product was found to degrade significantly in oxidative, acid, and base hydrolysis degradation conditions, and the degradation products were well determined from the active peaks, thus proving the stability-indicating power of the method. The developed and validated stability-indicating reversed-phase-HPLC method was appropriate for quantitative determination of these drugs in pharmaceutical preparations and also for quality control in bulk manufacturing.     

Stabilized catalyst comprising nickel and supported 12-tungstophosphoric acid: synthesis,characterization and aqueous-phase Suzuki–Miyaura cross-coupling

Transition Metal Chemistry - This work describes a simple impregnation and soaking method for designing of stabilized nickel exchanged supported 12-tungstophosphoric acid, its characterization and...